![Han-Gu Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 4 M $ au 30/06/2026
Han-Gu Lee worked as the Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd., HLB Pharmaceutical Co., Ltd., and RedoxBio Co., Ltd. He started his job at HLB Pharmaceutical Co., Ltd. in 2016 and ended it in 2017.
Dr. Lee received his undergraduate and doctorate degrees from Sungkyunkwan University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/12/2025 | 596 327 ( 3,2% ) | 4 M $ | 30/06/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
RedoxBio Co., Ltd.
 RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Directeur Général | 31/05/2024 |
| HLB PHARMACEUTICAL CO., LTD. | Directeur Général | 31/05/2017 |
| DAE HWA PHARMACEUTICAL CO., LTD. | Directeur Général | 20/03/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
DAE HWA PHARM Co., Ltd.
 DAE HWA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sungkyunkwan University
 Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HLB Pharmaceutical Co., Ltd.
 HLB Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and related products based on biotechnology | Health Technology |
RedoxBio Co., Ltd.
RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
